Poster presentations level of feacal calprotectin than those with active histological inflammation (107 µg/g vs. 416 µg/g, p = 0.016) (Figure 2 ). Using ROC curve, faecal calprotectin <250 µg/g predicted endoscopic remission (MES ≤ 1) with a sensitivity of 67% and specificity of 77% while faecal calprotectin <200 µg/g predicted histological remission with a sensitivity of 71% and specificity of 76%. Conclusions: Faecal calprotectin levels correlate with both endoscopic and histological activity and are reliable biomarkers in assessing mucosal healing in UC.
Background: Histological healing in ulcerative colitis (UC) may be a better predictor than macroscopic appearance or clinical criteria for time to relapse. Indicators of acute mucosal inflammation which are used in the Riley Score or the Nancy index are associated with a two-to threefold increase in the risk of UC relapse during 12 months' follow-up. However histologic assessment requires invasive endoscopy and gaining of biopsy. Non-invasive surrogates of mucosal healing would help to lower risks, costs and might increase patient acceptance. Fecal biomarkers are frequently used in UC and might be of help in this endeavour. The study aimed to investigate the performance of non-invasive faecal biomarkers compared with the Riley Score and Nancy index in patients with UC. Methods: Colonoscopy was performed in every patient and a faecal sample was harvested within 72 h. Three biopsies were taken from the macroscopically most inflamed location or random from each colonic segment and Riley Score and Nancy index were calculated. For each patient the highest calculated score was compared with the faecal biomarkers Lactoferrin (LF), Calprotectin (CALPRESTCalP), PMN elastase (PMN-E), S100 calcium-binding protein A12 (S100A12) and Eosinophil-derived Neurotoxin (EDN). It was evaluated if the median levels of the fecal markers differ significantly between the grades 0-4 of the Nancy index. Results: 50 patients (32 female), mean age 42.9 ± 12.3 years (range 23-67) with diagnosed UC were included. The Riley score and the Nancy index correlated with EDN (r (49) Table 1 . LF, EDN and CalP differed significantly between the grades. Post-hoc tests showed that LF differed significantly between the grades 2 and 3 (z = −3.13, p = .011), EDN between the grades 2 and 4 (z = −3.01, p = .016) and S100A12 between the grades 2 and 3 (z = −3.97, p = .000) and 2 and 4 (z = −3.07, p = .013).
Conclusions:
The fecal biomarkers LF, EDN, S100A12 and PMN-e were correlated significantly with the Riley and Nancy index, LF, EDN and CalP differed significantly between the grades of the Nancy index. The results support the utility of fecal biomarkers for detecting active histologic inflammation in patients with ulcerative colitis. 181 [169; 720] ng/ml) (p < 0.001). To determine the presence of UC, the sensitivity of lipocalin 2 was 78%, the specificity was 93%, and the AUC was 0.93 at a threshold value of 1132 ng/ ml. The diagnostic value of fecal lipocalin 2 as a marker of exacerbation of UC relative to remission of the disease showed other result: sensitivity -78% and specificity of 40% and AUC of 0.63 at a threshold value of 1132 ng/ml. Conclusions: Patients with active UC had an increased level of sucralose in urine, which had high specificity both for detecting the presence of UC and for determining exacerbation. Fecal lipocalin 2 had high sensitivity and specificity for screening the disease. 
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